The Michael E. DeBakey VA Medical Center, Houston, Texas; Section of Cardiology, Baylor College of Medicine, Houston, Texas; The Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Heart, New York, New York.
Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
Am J Cardiol. 2020 Sep 15;131:23-26. doi: 10.1016/j.amjcard.2020.06.043. Epub 2020 Jun 30.
The 2017 American Heart Association Scientific Statement on meditation and cardiovascular risk suggested that meditation may be considered as an adjunct to guideline-directed cardiovascular risk-reduction interventions. Meditation could potentially increase physical and mental relaxation, leading to improved outcomes after a major cardiovascular event. We hypothesized that meditation is associated with lower cardiovascular risk in the US general population. Using data from the 2012 and 2017 National Health Interview Survey, we identified all patients with hypercholesterolemia, systemic hypertension (SH), diabetes mellitus (DM), stroke, and coronary artery disease (CAD), as well as those who reported that they meditate. Multivariable logistic regression analyses were performed to evaluate the association between meditation and risk of hypercholesterolemia, SH, DM, stroke, and CAD, adjusting for potential confounders. Of 61,267 the National Health Interview Survey participants, 5,851 (9.6%) participated in some form of meditation. After adjusting for age, gender, body mass index, race, marital status, cigarette smoking, sleeping duration, and depression, meditation was independently associated with a lower prevalence of hypercholesterolemia (odds ratio [OR] 0.65; 95% confidence interval [CI] 0.54 to 0.79; p = 0.001), SH (OR 0.86; 95% CI 0.75 to 0.99; p = 0.04), diabetes (OR 0.70; 95% CI 0.59 to 0.84; p = 0.0001), stroke (OR 0.76; 95% CI 0.58 to 0.99; p = 0.04), or CAD (OR 0.51; 95% CI 0.39 to 0.66; p <0.001), compared with those who did not meditate. In conclusion, using a large national database, we found that meditation is associated with a lower prevalence of cardiovascular risks factors and disease.
2017 年美国心脏协会科学声明建议冥想可被视为指导心血管风险降低干预措施的辅助手段。冥想可能会增加身体和精神的放松，从而改善重大心血管事件后的结果。我们假设冥想与美国普通人群的心血管风险较低有关。使用 2012 年和 2017 年全国健康访谈调查的数据，我们确定了所有患有高胆固醇血症、全身性高血压（SH）、糖尿病（DM）、中风和冠心病（CAD）的患者，以及那些报告他们冥想的患者。进行多变量逻辑回归分析，以评估冥想与高胆固醇血症、SH、DM、中风和 CAD 风险之间的关联，调整潜在混杂因素。在 61267 名国家健康访谈调查参与者中，有 5851 人（9.6%）参加了某种形式的冥想。调整年龄、性别、体重指数、种族、婚姻状况、吸烟、睡眠时间和抑郁情况后，冥想与较低的高胆固醇血症患病率独立相关（比值比 [OR] 0.65；95%置信区间 [CI] 0.54 至 0.79；p=0.001）、SH（OR 0.86；95%CI 0.75 至 0.99；p=0.04）、糖尿病（OR 0.70；95%CI 0.59 至 0.84；p=0.0001）、中风（OR 0.76；95%CI 0.58 至 0.99；p=0.04）或 CAD（OR 0.51；95%CI 0.39 至 0.66；p<0.001）相比，不冥想的参与者。总之，使用大型国家数据库，我们发现冥想与心血管风险因素和疾病的患病率较低有关。
